{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:04:36Z","timestamp":1782727476894,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,31]]},"DOI":"10.7759\/cureus.34431","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T10:42:51Z","timestamp":1675161771000},"source":"Crossref","is-referenced-by-count":5,"title":["Reactivation of Herpes Zoster After Recombinant Vaccine (Shingrix): A Case Report"],"prefix":"10.7759","author":[{"given":"Feras","family":"Altukhaim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Mutlaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salha","family":"Hakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1302674","article-title":"Clinical practice: herpes zoster","volume":"369","author":"Cohen JI","year":"2013","unstructured":"Cohen JI. Clinical practice: herpes zoster. N Engl J Med. 2013, 369:255-63. 10.1056\/NEJMcp1302674","journal-title":"N Engl J Med"},{"key":"ref2","unstructured":"Shingles (herpes zoster). (2022). Accessed. February 10, 2022: https:\/\/www.cdc.gov\/shingles\/index.html."},{"key":"ref3","article-title":"Shingrix for herpes zoster: a review","volume":"24","author":"Shah RA","year":"2019","unstructured":"Shah RA, Limmer AL, Nwannunu CE, Patel RR, Mui UN, Tyring SK. Shingrix for herpes zoster: a review. Skin Therapy Lett. 2019, 24:5-7.","journal-title":"Skin Therapy Lett"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0088-1","article-title":"Shingles (herpes zoster) vaccine (zostavax\u00ae): a review of its use in the prevention of herpes zoster and postherpetic neuralgia in adults aged \u226550 years","volume":"73","author":"Keating GM","year":"2013","unstructured":"Keating GM. Shingles (herpes zoster) vaccine (zostavax\u00ae): a review of its use in the prevention of herpes zoster and postherpetic neuralgia in adults aged \u226550 years. Drugs. 2013, 73:1227-44. 10.1007\/s40265-013-0088-1","journal-title":"Drugs"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1956906","article-title":"A practitioner's guide to the recombinant zoster vaccine: review of national vaccination recommendations","volume":"20","author":"Parikh R","year":"2021","unstructured":"Parikh R, Widenmaier R, Lecrenier N. A practitioner's guide to the recombinant zoster vaccine: review of national vaccination recommendations. Expert Rev Vaccines. 2021, 20:1065-75. 10.1080\/14760584.2021.1956906","journal-title":"Expert Rev Vaccines"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/1060028018758431","article-title":"Shingrix: the new adjuvanted recombinant herpes zoster vaccine","volume":"52","author":"James SF","year":"2018","unstructured":"James SF, Chahine EB, Sucher AJ, Hanna C. Shingrix: the new adjuvanted recombinant herpes zoster vaccine. Ann Pharmacother. 2018, 52:673-80. 10.1177\/1060028018758431","journal-title":"Ann Pharmacother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1495565","article-title":"Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention","volume":"17","author":"Lecrenier N","year":"2018","unstructured":"Lecrenier N, Beukelaers P, Colindres R, et al.. Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention. Expert Rev Vaccines. 2018, 17:619-34. 10.1080\/14760584.2018.1495565","journal-title":"Expert Rev Vaccines"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2019.02.009","article-title":"Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine","volume":"59","author":"Heineman TC","year":"2019","unstructured":"Heineman TC, Cunningham A, Levin M. Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine. Curr Opin Immunol. 2019, 59:42-8. 10.1016\/j.coi.2019.02.009","journal-title":"Curr Opin Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-018-0603-x","article-title":"Recombinant zoster vaccine (Shingrix\u00ae): a review in herpes zoster","volume":"35","author":"Syed YY","year":"2018","unstructured":"Syed YY. Recombinant zoster vaccine (Shingrix\u00ae): a review in herpes zoster. Drugs Aging. 2018, 35:1031-40. 10.1007\/s40266-018-0603-x","journal-title":"Drugs Aging"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2022.2071118","article-title":"Dermatomal rash after Shingrix vaccination: cause or coincidence?","volume":"35","author":"Mittal N","year":"2022","unstructured":"Mittal N, Dhir N, Mittal N. Dermatomal rash after Shingrix vaccination: cause or coincidence?. Proc (Bayl Univ Med Cent). 2022, 35:686-7. 10.1080\/08998280.2022.2071118","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.07.033","article-title":"Herpes zoster after recombinant zoster vaccine: a first case report","volume":"8","author":"Housel LA","year":"2020","unstructured":"Housel LA, McClenathan BM. Herpes zoster after recombinant zoster vaccine: a first case report. J Allergy Clin Immunol Pract. 2020, 8:772-4.e1. 10.1016\/j.jaip.2019.07.033","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000522272","article-title":"Reactivation of herpes zoster keratitis following Shingrix vaccine","volume":"13","author":"Lu TJ","year":"2022","unstructured":"Lu TJ, Ta CN. Reactivation of herpes zoster keratitis following Shingrix vaccine. Case Rep Ophthalmol. 2022, 13:104-8. 10.1159\/000522272","journal-title":"Case Rep Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1016672","article-title":"Epidemiology of herpes zoster among adults aged 50 and above in Guangdong, China","volume":"11","author":"Zhu Q","year":"2015","unstructured":"Zhu Q, Zheng H, Qu H, et al.. Epidemiology of herpes zoster among adults aged 50 and above in Guangdong, China. Hum Vaccin Immunother. 2015, 11:2113-8. 10.1080\/21645515.2015.1016672","journal-title":"Hum Vaccin Immunother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2012.06.020","article-title":"Herpes zoster: family history and psychological stress-case-control study","volume":"55","author":"Lasserre A","year":"2012","unstructured":"Lasserre A, Blaizeau F, Gorwood P, et al.. Herpes zoster: family history and psychological stress-case-control study. J Clin Virol. 2012, 55:153-7. 10.1016\/j.jcv.2012.06.020","journal-title":"J Clin Virol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5742\/MEWFM.2022.9525130","article-title":"Trends in herpes zoster infection in Saudi Arabia; a call for expanding access to shingles vaccination","volume":"20","author":"Alqifari SF","year":"2022","unstructured":"Alqifari SF, Aldawish RF, Binsaqr MA, Khojah AA, Alshammari MR, Esmail AK, Al-Rasheedi M. Trends in herpes zoster infection in Saudi Arabia; a call for expanding access to shingles vaccination. World Fam Med J\/Middle East J Fam Med. 2022, 20:6-13. 10.5742\/MEWFM.2022.9525130","journal-title":"World Fam Med J\/Middle East J Fam Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-018-0394-4","article-title":"Herpes zoster and diabetes mellitus: a review","volume":"9","author":"Papagianni M","year":"2018","unstructured":"Papagianni M, Metallidis S, Tziomalos K. Herpes zoster and diabetes mellitus: a review. Diabetes Ther. 2018, 9:545-50. 10.1007\/s13300-018-0394-4","journal-title":"Diabetes Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/135676-reactivation-of-herpes-zoster-after-recombinant-vaccine-shingrix-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:50:56Z","timestamp":1707508256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/135676-reactivation-of-herpes-zoster-after-recombinant-vaccine-shingrix-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.34431","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,31]]}}}